Home › Funds › THOMPSON SIEGEL & WALMSLEY LLC › IQV
THOMPSON SIEGEL & WALMSLEY LLC position in IQV
IQVIA HLDGS INC · Health Care
THOMPSON SIEGEL & WALMSLEY LLC reported holding 309,534 shares of IQV (IQVIA HLDGS INC) in its Q2 2026 13F filing — a position valued at US$59.8M, representing 1.08% of its reported portfolio and ranking #18 among its reported holdings. THOMPSON SIEGEL & WALMSLEY LLC has disclosed IQV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How THOMPSON SIEGEL & WALMSLEY LLC's IQV position evolved
THOMPSON SIEGEL & WALMSLEY LLC first disclosed a stake in IQV in Q3 2023 at 17,900 shares (US$3.5M). The position peaked in Q2 2026 at 309,534 shares, worth US$59.8M. Across 12 filings, THOMPSON SIEGEL & WALMSLEY LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 309,534 shares valued at US$59.8M. Notable position changes include a 469% increase in Q4 2024 (shares fell 10% over the following quarter), a 90% trim in Q2 2025 (shares rose 21% over the following quarter), a 1295% increase in Q3 2025 (shares rose 19% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 17.90K | $3.52M | New |
| Q4 2023 | 15.70K | $3.63M | Reduce |
| Q1 2024 | 15.70K | $3.97M | Hold |
| Q2 2024 | 18.29K | $3.87M | Add |
| Q3 2024 | 22.29K | $5.28M | Add |
| Q4 2024 | 126.84K | $24.93M | Add |
| Q1 2025 | 192.90K | $34.01M | Add |
| Q2 2025 | 20.00K | $3.15M | Reduce |
| Q3 2025 | 278.99K | $52.99M | Add |
| Q4 2025 | 203.50K | $45.87M | Reduce |
| Q1 2026 | 308.47K | $52.61M | Add |
| Q2 2026 | 309.53K | $59.81M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IQV and 13F data
IQV (IQVIA HLDGS INC) is a Health Care company. 24 other funds we track also report a position in IQV — the largest reported positions include Harris Associates (Oakmark) (US$2.35B), HARRIS ASSOCIATES L P (US$2.35B), Artisan Partners Limited Partnership (US$916.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IQV
- Harris Associates (Oakmark) 12.18M sh · $2.35B · Q2 2026
- HARRIS ASSOCIATES L P 12.18M sh · $2.35B · Q2 2026
- Artisan Partners Limited Partnership 4.74M sh · $916.53M · Q2 2026
- Boston Partners 4.47M sh · $865.50M · Q2 2026
- Longview Partners (Guernsey) LTD 1.50M sh · $289.98M · Q2 2026
More on THOMPSON SIEGEL & WALMSLEY LLC
FAQ
How long has THOMPSON SIEGEL & WALMSLEY LLC held IQV?
THOMPSON SIEGEL & WALMSLEY LLC has disclosed IQV holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is THOMPSON SIEGEL & WALMSLEY LLC's current position in IQV?
As of Q2 2026, THOMPSON SIEGEL & WALMSLEY LLC holds 309.53K shares of IQV (IQVIA HLDGS INC), valued at $59.81M, representing 1.08% of its reported portfolio and ranking #18.
Has THOMPSON SIEGEL & WALMSLEY LLC been buying or selling IQV?
In the latest 13F filing (Q2 2026), THOMPSON SIEGEL & WALMSLEY LLC held unchanged its position in IQV. The position peaked in Q2 2026 at 309.53K shares.
Which other funds hold IQV?
Other major institutional holders of IQV include Harris Associates (Oakmark), HARRIS ASSOCIATES L P, Artisan Partners Limited Partnership, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.